MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

Vinblastine sulfate

CAS No. : 143-67-9

MCE 國(guó)際站：Vinblastine sulfate

產(chǎn)品活性：Vinblastine sulfate是一種針對(duì)各種癌癥類型的有細(xì)胞毒性的生物堿。 長(zhǎng)春花堿可抑制微管的形成，抑制nAChR的IC₅₀值為8.9 μM。

研究領(lǐng)域：Cell Cycle/DNA Damage  |  Cytoskeleton  |  Autophagy

作用靶點(diǎn)：Microtubule/Tubulin  |  Autophagy

結(jié)構(gòu)分類：生物堿  |  生物堿二聚體

來(lái)源：植物  |  夾竹桃科  |  長(zhǎng)春花

In Vitro: Vinblastine does not depolymerize spindle microtubules, yet it powerfully blocks mitosis (for example, IC₅₀ 0.8 nM in HeLa cells) and cells die by apoptosis. In NB4 cells, vinblastine produces alteration of p53 and DNA fragmentation. Vinblastine treatment has an antiproliferative effect via the induction of apoptosis producing Bax/Bcl-2 imbalance. Vinblastine treatment suppresses NFκB expression and depresses NFκB-DNA binding activity while maintaining JNK activation that subsequently results in apoptotic response through caspase-dependent pathway. Vinblastine is found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential, the release of both cytochrome c and apoptosis inducing factor, activation of caspase-9 and 3, and cleavage of Poly (ADP-ribose)-Polymerase.

In Vivo: Vinblastine is a widely used anticancer drug with undesired side effects. Its conjugation with carrier molecules could be an efficient strategy to reduce these side effects.

相關(guān)產(chǎn)品：Natural Product Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Natural Product Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  CNS-Penetrant Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  NMPA-Approved Drug Library  |  Medicine Food Homology Compound Library  |  Cytoskeleton Compound Library  |  Traditional Chinese Medicine Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Alkaloids Library  |  Anti-Lung Cancer Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  Anti-Cancer Natural Product Library  |  Protein-protein Interaction Inhibitor Library  |  Chemotherapy Drug Library  |  Plant-Sourced Natural Product Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Anti-Prostate Cancer Compound Library  |  Off-patent Drug Library  |  Cell Death Library  |  FDA-Approved Traditional Chinese Medicine Active Compound Library  |  Tirbanibulin dihydrochloride  |  Tubulysin IM-3  |  AMXI-5001 hydrochloride  |  Tubulin polymerization-IN-21  |  Dolastatin 10  |  SB-216  |  MAP4343  |  Tubulin polymerization-IN-8  |  Tubulysin IM-1  |  Colchicine-d₃  |  2-Methoxyestradiol-¹³C,d₃  |  Taltobulin  |  Albendazole  |  Tilavonemab  |  DM4-d₆  |  EGFR-IN-57  |  Epothilone B  |  Epothilone A  |  Maytansinol  |  Docetaxel-d₉  |  Anticancer agent 139  |  Verubulin hydrochloride  |  VcMMAE  |  Tubulin polymerization-IN-15  |  Combretastatin A-1  |  Tubulin/HDAC-IN-1  |  Mc-MMAE  |  7-epi-Taxol  |  Thiocolchicine  |  Fosbretabulin disodium

熱門產(chǎn)品線：重組蛋白  |  化合物庫(kù)  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物  |  寡核苷酸  |  抗體  |  點(diǎn)擊化學(xué)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry